Facility Tours

Take advantage of a unique opportunity to see world-class pharmaceutical facilities by attending a facility tour during the 2018 ISPE Biopharmaceutical Manufacturing Conference.  


Wednesday, 12 December

Facility Tour | US$55
1200 - 1700

Facility Tour Option 1: Dendreon Pharmaceuticals, LLC

Dendreon-Headquarter-Seal-Beach-2 pictureDendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 30,000 men with advanced prostate cancer have been prescribed PROVENGE since 2010. Please join us at Dendreon’s headquarters in Seal Beach, Calif. for a tour of its Seal Beach manufacturing facility and learn more about how Dendreon successfully commercialized the first active cellular immunotherapy approved for use in the United States.

Register

Facility Tour Option 2: Avid Bioservices, Inc

Avid Bioservices, Inc Facility Tour at 2018 ISPE Biopharma Manufacturing ConferenceJoin us for a tour of Avid Bioservices’ Myford Late-Stage Clinical and Commercial Biomanufacturing Facility, located in Tustin, California. Learn about Avid's comprehensive range of services structured to support your project from early development through commercial manufacturing. Touring the facility, you will see first-hand the design features incorporated into the Myford facility, which provide flexible and efficient solutions to meet client challenges and timelines. Avid's services include process development and cGMP clinical and commercial manufacturing as well as stability testing for drug substance and drug product. The company focuses on biotherapeutics derived from cell culture processes. Avid provides a variety of process development activities to ensure a robust manufacture and market ready process including cell line development and optimization, cell culture and feed optimization, analytical method development and product characterization. The Myford facility incorporates a variety of cutting-edge, single-use equipment offering a fully disposable biomanufacturing process. A wide range of innovative features are incorporated into the facility including monolithic modular clean rooms, dedicated support utilities for each key processing area, and the industry’s most advanced single-use production systems and flexible solutions. Uni-directional process flows separate personnel and materials and provide assurance that the design meets the most stringent regulatory requirements for commercial biologics drug substance manufacturing. This facility complements Avid’s legacy commercial facility, located on the same campus, which continues to be responsible for the manufacture of globally marketed commercial products.

Register